Swedish tissue giant Essity has initiated a strategic review of its Consumer Tissue business area’s global operations, a move it said will evaluate different alternatives that “may lead to separation, although no such decisions have yet been taken.”
In 2025, the division’s net sales were SEK43,537m, or 31% of the group’s net sales, while EBITA excl. IAC amounted to SEK5,187m.
The company said it “continuously evaluates its product portfolio to increase long-term value creation”.
It said: “With the review, different alternatives will be evaluated and may lead to separation, although no such decisions have yet been taken.”
Ulrika Kolsrud, President and Chief Executive, said: “Essity’s Consumer Tissue business has a strong offering under its own brands, retailer brands, and through private label, with leading market positions and an efficient supply chain.
“The strategic review will evaluate different options for the ownership of Consumer Tissue and is part of our efforts to optimise Essity’s product portfolio and maximise value creation.
The business includes products such as toilet paper, household towels, handkerchiefs, facial tissues, moist tissue and paper napkins under brands such as Lotus, Tempo, Zewa, Cushelle, Plenty, Regio and Familia.
Essity also produces consumer tissue for retailer’s own brands and private label.
In Consumer Tissue, Essity is the market leader in Europe and the second largest player in Latin America.
